Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Ketamine Increases Proliferation of Human iPSC-Derived Neuronal Progenitor Cells via Insulin-Like Growth Factor 2 and Independent of the NMDA Receptor.

Grossert A, Mehrjardi NZ, Bailey SJ, Lindsay MA, Hescheler J, Šarić T, Teusch N.

Cells. 2019 Sep 24;8(10). pii: E1139. doi: 10.3390/cells8101139.

2.

Long Non-Coding RNAs and the Innate Immune Response.

Hadjicharalambous MR, Lindsay MA.

Noncoding RNA. 2019 Apr 19;5(2). pii: E34. doi: 10.3390/ncrna5020034. Review.

3.

Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis.

Hadjicharalambous MR, Roux BT, Csomor E, Feghali-Bostwick CA, Murray LA, Clarke DL, Lindsay MA.

Sci Rep. 2019 Apr 15;9(1):6020. doi: 10.1038/s41598-019-42292-w.

4.

Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts.

Hadjicharalambous MR, Roux BT, Feghali-Bostwick CA, Murray LA, Clarke DL, Lindsay MA.

Front Immunol. 2018 Dec 11;9:2906. doi: 10.3389/fimmu.2018.02906. eCollection 2018.

5.

Design Analysis and Optimization of a Single-Layer PDMS Microfluidic Artificial Lung.

Thompson AJ, Ma LJ, Plegue TJ, Potkay JA.

IEEE Trans Biomed Eng. 2019 Apr;66(4):1082-1093. doi: 10.1109/TBME.2018.2866782. Epub 2018 Aug 22.

PMID:
30139043
6.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.

7.

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.

Jadon DR, Sengupta R, Nightingale A, Lu H, Dunphy J, Green A, Elder JT, Nair RP, Korendowych E, Lindsay MA, McHugh NJ.

Arthritis Res Ther. 2017 Sep 21;19(1):210. doi: 10.1186/s13075-017-1417-7.

8.

Catalog of Differentially Expressed Long Non-Coding RNA following Activation of Human and Mouse Innate Immune Response.

Roux BT, Heward JA, Donnelly LE, Jones SW, Lindsay MA.

Front Immunol. 2017 Aug 29;8:1038. doi: 10.3389/fimmu.2017.01038. eCollection 2017.

9.

Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis.

Hamann PD, Roux BT, Heward JA, Love S, McHugh NJ, Jones SW, Lindsay MA.

Sci Rep. 2017 Aug 14;7(1):8024. doi: 10.1038/s41598-017-08603-9.

10.

Corrigendum: Highly sensitive dual mode electrochemical platform for microRNA detection.

Jolly P, Batistuti MR, Miodek A, Zhurauski P, Mulato M, Lindsay MA, Estrela P.

Sci Rep. 2017 Jan 23;7:41110. doi: 10.1038/srep41110. No abstract available.

11.

Whole Transcriptome Analysis of Pre-invasive and Invasive Early Squamous Lung Carcinoma in Archival Laser Microdissected Samples.

Koper A, Zeef LA, Joseph L, Kerr K, Gosney J, Lindsay MA, Booton R.

Respir Res. 2017 Jan 10;18(1):12. doi: 10.1186/s12931-016-0496-3.

12.

Highly sensitive dual mode electrochemical platform for microRNA detection.

Jolly P, Batistuti MR, Miodek A, Zhurauski P, Mulato M, Lindsay MA, Estrela P.

Sci Rep. 2016 Nov 8;6:36719. doi: 10.1038/srep36719. Erratum in: Sci Rep. 2017 Jan 23;7:41110.

13.

Clinical potential of oligonucleotide-based therapeutics in the respiratory system.

Moschos SA, Usher L, Lindsay MA.

Pharmacol Ther. 2017 Jan;169:83-103. doi: 10.1016/j.pharmthera.2016.10.009. Epub 2016 Oct 19. Review.

PMID:
27771436
14.

Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.

Pomerenke A, Lea SR, Herrick S, Lindsay MA, Singh D.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 29;11:2409-2417. eCollection 2016.

15.

Knockdown of Nuclear-Located Enhancer RNAs and Long ncRNAs Using Locked Nucleic Acid GapmeRs.

Roux BT, Lindsay MA, Heward JA.

Methods Mol Biol. 2017;1468:11-8. doi: 10.1007/978-1-4939-4035-6_2.

PMID:
27662866
16.

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials.

Press MF, Sauter G, Buyse M, Fourmanoir H, Quinaux E, Tsao-Wei DD, Eiermann W, Robert N, Pienkowski T, Crown J, Martin M, Valero V, Mackey JR, Bee V, Ma Y, Villalobos I, Campeau A, Mirlacher M, Lindsay MA, Slamon DJ.

J Clin Oncol. 2016 Oct 10;34(29):3518-3528. doi: 10.1200/JCO.2016.66.6693.

17.

Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle.

Austin PJ, Tsitsiou E, Boardman C, Jones SW, Lindsay MA, Adcock IM, Chung KF, Perry MM.

J Allergy Clin Immunol. 2017 Mar;139(3):780-789. doi: 10.1016/j.jaci.2016.06.014. Epub 2016 Jul 2.

18.

Long Intergenic Noncoding RNAs Mediate the Human Chondrocyte Inflammatory Response and Are Differentially Expressed in Osteoarthritis Cartilage.

Pearson MJ, Philp AM, Heward JA, Roux BT, Walsh DA, Davis ET, Lindsay MA, Jones SW.

Arthritis Rheumatol. 2016 Apr;68(4):845-56. doi: 10.1002/art.39520.

19.

Statistical controversies in clinical research: statistical significance-too much of a good thing ….

Buyse M, Hurvitz SA, Andre F, Jiang Z, Burris HA, Toi M, Eiermann W, Lindsay MA, Slamon D.

Ann Oncol. 2016 May;27(5):760-2. doi: 10.1093/annonc/mdw047. Epub 2016 Feb 9. Review.

PMID:
26861602
20.

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.

Ngkelo A, Hoffmann RF, Durham AL, Marwick JA, Brandenburg SM, de Bruin HG, Jonker MR, Rossios C, Tsitsiou E, Caramori G, Contoli M, Casolari P, Monaco F, Andò F, Speciale G, Kilty I, Chung KF, Papi A, Lindsay MA, Ten Hacken NH, van den Berge M, Timens W, Barnes PJ, van Oosterhout AJ, Adcock IM, Kirkham PA, Heijink IH.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 15;309(10):L1112-23. doi: 10.1152/ajplung.00077.2015. Epub 2015 Aug 28.

21.

Reply to H.J. Lee et al.

Mackey JR, Houé V, Thireau F, Lindsay MA, Fresco R.

J Clin Oncol. 2015 Aug 20;33(24):2712-3. doi: 10.1200/JCO.2015.61.6748. Epub 2015 Jul 20. No abstract available.

PMID:
26195708
22.

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.

Hurvitz SA, Andre F, Jiang Z, Shao Z, Mano MS, Neciosup SP, Tseng LM, Zhang Q, Shen K, Liu D, Dreosti LM, Burris HA, Toi M, Buyse ME, Cabaribere D, Lindsay MA, Rao S, Pacaud LB, Taran T, Slamon D.

Lancet Oncol. 2015 Jul;16(7):816-29. doi: 10.1016/S1470-2045(15)00051-0. Epub 2015 Jun 16.

PMID:
26092818
23.

Corrigendum: Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes.

Ilott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L, Goodhead I, Hertz-Fowler C, Heger A, Hall N, Donnelly LE, Sims D, Lindsay MA.

Nat Commun. 2015 Apr 9;6:6814. doi: 10.1038/ncomms7814. No abstract available.

24.

LincRNA signatures in human lymphocytes.

Roux BT, Lindsay MA.

Nat Immunol. 2015 Mar;16(3):220-2. doi: 10.1038/ni.3106. No abstract available.

PMID:
25689433
25.

Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells.

Heward JA, Roux BT, Lindsay MA.

FEBS Lett. 2015 Jan 30;589(3):396-406. doi: 10.1016/j.febslet.2014.12.026. Epub 2014 Dec 29.

26.

Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy.

Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R.

J Rheumatol. 2015 Jan;42(1):21-30. doi: 10.3899/jrheum.140223. Epub 2014 Nov 1. Review.

PMID:
25362660
27.

Long non-coding RNAs in the regulation of the immune response.

Heward JA, Lindsay MA.

Trends Immunol. 2014 Sep;35(9):408-19. doi: 10.1016/j.it.2014.07.005. Epub 2014 Aug 8. Review.

PMID:
25113636
28.

Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease.

Booton R, Lindsay MA.

Chest. 2014 Jul;146(1):193-204. doi: 10.1378/chest.13-2736. Review.

PMID:
25010962
29.

Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes.

IIott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L, Goodhead I, Hertz-Fowler C, Heger A, Hall N, Donnelly LE, Sims D, Lindsay MA.

Nat Commun. 2014 Jun 9;5:3979. doi: 10.1038/ncomms4979. Erratum in: Nat Commun. 2015;6:6814.

30.

Role of non-coding RNAs in maintaining primary airway smooth muscle cells.

Perry MM, Tsitsiou E, Austin PJ, Lindsay MA, Gibeon DS, Adcock IM, Chung KF.

Respir Res. 2014 May 16;15:58. doi: 10.1186/1465-9921-15-58.

31.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

32.

Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1.

Kankaanranta H, Ilmarinen P, Zhang X, Adcock IM, Lahti A, Barnes PJ, Giembycz MA, Lindsay MA, Moilanen E.

PLoS One. 2014 Feb 28;9(2):e90298. doi: 10.1371/journal.pone.0090298. eCollection 2014.

33.

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

Mackey JR, Martin M, Pienkowski T, Rolski J, Guastalla JP, Sami A, Glaspy J, Juhos E, Wardley A, Fornander T, Hainsworth J, Coleman R, Modiano MR, Vinholes J, Pinter T, Rodríguez-Lescure A, Colwell B, Whitlock P, Provencher L, Laing K, Walde D, Price C, Hugh JC, Childs BH, Bassi K, Lindsay MA, Wilson V, Rupin M, Houé V, Vogel C; TRIO/BCIRG 001 investigators.

Lancet Oncol. 2013 Jan;14(1):72-80. doi: 10.1016/S1470-2045(12)70525-9. Epub 2012 Dec 12.

PMID:
23246022
34.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.

35.

Adjuvant trastuzumab in HER2-positive breast cancer.

Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group.

N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383.

36.

Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma.

Tsitsiou E, Williams AE, Moschos SA, Patel K, Rossios C, Jiang X, Adams OD, Macedo P, Booton R, Gibeon D, Chung KF, Lindsay MA.

J Allergy Clin Immunol. 2012 Jan;129(1):95-103. doi: 10.1016/j.jaci.2011.08.011. Epub 2011 Sep 13.

PMID:
21917308
37.

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

Eiermann W, Pienkowski T, Crown J, Sadeghi S, Martin M, Chan A, Saleh M, Sehdev S, Provencher L, Semiglazov V, Press M, Sauter G, Lindsay MA, Riva A, Buyse M, Drevot P, Taupin H, Mackey JR.

J Clin Oncol. 2011 Oct 10;29(29):3877-84. doi: 10.1200/JCO.2010.28.5437. Epub 2011 Sep 12.

PMID:
21911726
38.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

39.

Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study.

Martin M, Roche H, Pinter T, Crown J, Kennedy MJ, Provencher L, Priou F, Eiermann W, Adrover E, Lang I, Ramos M, Latreille J, Jagiełło-Gruszfeld A, Pienkowski T, Alba E, Snyder R, Almel S, Rolski J, Munoz M, Moroose R, Hurvitz S, Baños A, Adewoye H, Hei YJ, Lindsay MA, Rupin M, Cabaribere D, Lemmerick Y, Mackey JR; TRIO 010 investigators.

Lancet Oncol. 2011 Apr;12(4):369-76. doi: 10.1016/S1470-2045(11)70037-7. Epub 2011 Mar 21. Erratum in: Lancet Oncol. 2011 Aug;12(8):722.

PMID:
21429799
40.

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

Press MF, Sauter G, Buyse M, Bernstein L, Guzman R, Santiago A, Villalobos IE, Eiermann W, Pienkowski T, Martin M, Robert N, Crown J, Bee V, Taupin H, Flom KJ, Tabah-Fisch I, Pauletti G, Lindsay MA, Riva A, Slamon DJ.

J Clin Oncol. 2011 Mar 1;29(7):859-67. doi: 10.1200/JCO.2009.27.5644. Epub 2010 Dec 28.

41.

Measuring the action of CPP-siRNA conjugates in the lung.

Moschos SA, Spink KG, Lindsay MA.

Methods Mol Biol. 2011;683:417-29. doi: 10.1007/978-1-60761-919-2_30.

PMID:
21053147
42.

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S.

J Natl Cancer Inst Monogr. 2010;2010(41):162-77. doi: 10.1093/jncimonographs/lgq039. Review.

43.

Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle.

Larner-Svensson HM, Williams AE, Tsitsiou E, Perry MM, Jiang X, Chung KF, Lindsay MA.

Respir Res. 2010 Jun 2;11:68. doi: 10.1186/1465-9921-11-68.

44.

MicroRNAs and the regulation of fibrosis.

Jiang X, Tsitsiou E, Herrick SE, Lindsay MA.

FEBS J. 2010 May;277(9):2015-21. doi: 10.1111/j.1742-4658.2010.07632.x. Review.

45.

Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells.

Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA.

FEBS Lett. 2009 Oct 20;583(20):3349-55. doi: 10.1016/j.febslet.2009.09.038. Epub 2009 Sep 26.

46.

microRNAs and the immune response.

Tsitsiou E, Lindsay MA.

Curr Opin Pharmacol. 2009 Aug;9(4):514-20. doi: 10.1016/j.coph.2009.05.003. Epub 2009 Jun 12. Review.

47.

MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy.

Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM, Erjefalt JS, Chung KF, Lindsay MA.

PLoS One. 2009 Jun 12;4(6):e5889. doi: 10.1371/journal.pone.0005889.

48.

Targeting the lung using siRNA and antisense based oligonucleotides.

Moschos SA, Spinks K, Williams AE, Lindsay MA.

Curr Pharm Des. 2008;14(34):3620-7. Review.

PMID:
19075738
49.

Role of miRNA-146a in the regulation of the innate immune response and cancer.

Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1211-5. doi: 10.1042/BST0361211. Review.

PMID:
19021527
50.

microRNAs and the immune response.

Lindsay MA.

Trends Immunol. 2008 Jul;29(7):343-51. doi: 10.1016/j.it.2008.04.004. Review.

PMID:
18515182

Supplemental Content

Loading ...
Support Center